ARK Invest's trading activity during last week showed continued conviction in AI infrastructure, digital assets, and fintech ...
In late June 2026, Recursion Pharmaceuticals, Inc. was added to multiple Russell value and small-cap benchmarks, including ...
Recursion Pharmaceuticals has been trying to rebuild momentum after a steep five year decline in shareholder returns, yet its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results